Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

iFR Guided PCI to the LAD: Same as for non-LAD Vessels?

iFR has been validated as a useful tool for intermediate lesion analysis, with the advantage of not requiring the use of drugs. On the other hand, its use for PCI outcome assessment has not yet been thoroughly looked into, even though there have been promising data. 

ATC guiada por iFR ¿es igual en la descendente anterior que en el resto de los vasos?

24% of DEFINE PCI cases presented ≤0.89 iFR with a successful angiography. Those reaching ≥0.95 iFR at one year followup, showed lower incidence of cardiovascular mortality, MI, and ischemia driven revascularization. 

One analysis of the DEFINE PCI included the assessment of 506 vessels, 61.5% of the left anterior descending (LAD) and 38.5% to non-LAD vessels (99 left coronary, and 96 circumflex). It excluded cases with two vessels, which included the left main.

Primary end point at 12 months was target vessel failure, defined as a composite of cardiovascular death, MI and ischemia driven target vessel revascularization. 

There were no significant differences in bifurcation presence (4%), length (21.2 mm), stent diameter (3.0 mm) or maximum balloon pressure (18 ATM).

Read also: Can Ultrasound Treat Aortic Stenosis?

Calcified lesions in the LAD were more frequent (43.4% vs. 29.7%, p=0.002), reference vessel diameter was shorter (2.73 mm vs 2.84 mm, p<0.0001) and more post-dilation was required (63.8% vs. 51.5%, p=0.007).

Prior to PCI, LAD iFR was higher (0.82 [0.63, 0.86] vs. 0.72 [0.49, 0.84]; p<0.0001). After PCI, there were no angiographic differences in residual lesion, which was 19%.

Suboptimal iFR (<0.95) was higher in the LAD (77.8% vs 22.6%, p<0.0001). The presence of instent focal residual lesions was higher in the LAD (53.7% vs 27.3%, p=0.0009). There were no differences in primary end point at 12 months between the groups. 

In both groups, improved iFR after PCI was significantly associated with reduced angina and improved quality of life.

Read also: Revascularization vs. Deferral of Physiologically Significant Lesions in the Left Main Coronary Artery.

Independent predictors of low iFR after LAD PCI were age, larger body surface and smaller vessels; while in non-LAD lesions, predictors were calcifications and reference vessel diameter.

Conclusion

In conclusion, after PCI with successful PCI, iFR was lower in LAD lesions vs. non-LAD, which resulted in high prevalence of suboptimal iFR in the LAD. This disparity is attributed in part to a higher frequency of focal residual gradient within the stent segment, that might benefit from a more aggressive PCI.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Changes in post-PCI physiology based on anatomical vessel location: a DEFINE PCI substudy. 

Reference: Mitsuaki Matsumura, et al. EuroIntervention 2023;19-online publish-ahead-of-print November 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...

Calcified Nodules and Their Treatment with Rotational Atherectomy

Calcified nodules (CN) represent one of the most complex phenotypes to treat in coronary intervention. They are mainly associated with the need for repeat...

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...